<?xml version="1.0" encoding="UTF-8" standalone="no"?>

<MINiML
   xmlns="http://www.ncbi.nlm.nih.gov/geo/info/MINiML"
   xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
   xsi:schemaLocation="http://www.ncbi.nlm.nih.gov/geo/info/MINiML http://www.ncbi.nlm.nih.gov/geo/info/MINiML.xsd"
   version="0.5.0" >

  <Contributor iid="contrib1">
    <Person><First>BJ</First><Last>Yu</Last></Person>
    <Email>dolt@kaist.ac.kr</Email>
    <Phone>+82-42-860-4483</Phone>
    <Department>Systems Microbiology Research Center</Department>
    <Organization>KRIBB</Organization>
    <Address>
      <Line>52 Eoeun-dong Yuseong-gu</Line>
      <City>Daejeon</City>
      <Postal-Code>305-806</Postal-Code>
      <Country>South Korea</Country>
    </Address>
  </Contributor>

  <Contributor iid="contrib2">
    <Person><First>Pil</First><Last>Kim</Last></Person>
    <Email>kimp@catholic.ac.kr</Email>
    <Organization>Catholic Univ. of Korea</Organization>
    <Address>
      <Line>43-1 Yokkok2-dong</Line>
      <City>Bucheon</City>
      <State>Gyunggi</State>
      <Postal-Code>420-743</Postal-Code>
      <Country>South Korea</Country>
    </Address>
  </Contributor>

  <Contributor iid="contrib3">
    <Person><First>SUNG-HAN</First><Last>KIM</Last></Person>
  </Contributor>

  <Contributor iid="contrib4">
    <Person><First>DONG-YOON</First><Last>PARK</Last></Person>
  </Contributor>

  <Contributor iid="contrib5">
    <Person><First>LANG-HO</First><Last>LEE</Last></Person>
  </Contributor>

  <Contributor iid="contrib6">
    <Person><First>HAN-YONG</First><Last>LEE</Last></Person>
  </Contributor>

  <Contributor iid="contrib7">
    <Person><First>YOON-JUNG</First><Last>NAM</Last></Person>
  </Contributor>

  <Contributor iid="contrib8">
    <Person><First>HYE-YOUNG</First><Last>JEONG</Last></Person>
  </Contributor>

  <Contributor iid="contrib9">
    <Person><First>DONG-SOO</First><Last>RYU</Last></Person>
  </Contributor>

  <Contributor iid="contrib10">
    <Person><First>Jae</First><Middle>G</Middle><Last>Pan</Last></Person>
  </Contributor>

  <Contributor iid="contrib11">
    <Person><First>Byung</First><Middle>J</Middle><Last>Yu</Last></Person>
  </Contributor>

  <Database iid="GEO">
    <Name>Gene Expression Omnibus (GEO)</Name>
    <Public-ID>GEO</Public-ID>
    <Organization>NCBI NLM NIH</Organization>
    <Web-Link>http://www.ncbi.nlm.nih.gov/geo</Web-Link>
    <Email>geo@ncbi.nlm.nih.gov</Email>
  </Database>

  <Platform iid="GPL5482">
    <Status database="GEO">
      <Submission-Date>2007-07-11</Submission-Date>
      <Release-Date>2007-07-16</Release-Date>
      <Last-Update-Date>2007-07-20</Last-Update-Date>
    </Status>
    <Title>Escherichia coli 5K oligo microarray</Title>
    <Accession database="GEO">GPL5482</Accession>
    <Technology>spotted oligonucleotide</Technology>
    <Distribution>non-commercial</Distribution>
    <Organism taxid="562">Escherichia coli</Organism>
    <Manufacturer>DIGITAL GENOMICS</Manufacturer>
    <Manufacture-Protocol>
see manufacturer's web site
    </Manufacture-Protocol>
    <Support>glass</Support>
    <Coating>aminosilane</Coating>
    <Description>
Escherichia coli 5K oligo microarray produced by Digital Genomics, Inc. Seoul, Korea.
    </Description>
    <Web-Link>http://www.digital-genomics.com</Web-Link>
    <Contributor-Ref ref="contrib3" position="1" />
    <Contributor-Ref ref="contrib4" position="2" />
    <Contributor-Ref ref="contrib5" position="3" />
    <Contributor-Ref ref="contrib6" position="4" />
    <Contributor-Ref ref="contrib7" position="5" />
    <Contributor-Ref ref="contrib8" position="6" />
    <Contributor-Ref ref="contrib9" position="7" />
    <Contact-Ref ref="contrib2" />
    <Data-Table>
      <Column position="1">
        <Name>ID</Name>
      </Column>
      <Column position="2">
        <Name>SEQUENCE</Name>
        <Description>Probe sequence</Description>
      </Column>
      <Column position="3">
        <Name>LOCUS_TAG</Name>
        <Description>Blattner number</Description>
      </Column>
      <Column position="4">
        <Name>Gene_Name</Name>
        <Description>Gene symbol / name</Description>
      </Column>
      <Column position="5">
        <Name>Gene_Desc</Name>
        <Description>Gene description</Description>
      </Column>
      <Column position="6">
        <Name>ORF</Name>
        <Description>gene name  </Description>
        <Link-Prefix>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&amp;DB=gene&amp;cmd=search&amp;term=</Link-Prefix>
        <Link-Suffix>[gene name] AND Escherichia coli[organism]</Link-Suffix>
      </Column>
      <Column position="7">
        <Name>SPOT_ID</Name>
        <Description>spot identifier</Description>
      </Column>
    <External-Data rows="4819">
GPL5482-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Platform>

  <Sample iid="GSM435073">
    <Status database="GEO">
      <Submission-Date>2009-07-30</Submission-Date>
      <Release-Date>2009-07-31</Release-Date>
      <Last-Update-Date>2009-07-31</Last-Update-Date>
    </Status>
    <Title>Transcription profiles of NTG-treated E. coli imp fabI(G93V) and its control strain in the absence of triclosan</Title>
    <Accession database="GEO">GSM435073</Accession>
    <Type>RNA</Type>
    <Channel-Count>2</Channel-Count>
    <Channel position="1">
      <Source>NTG-treated E. coli imp fabI(G93V) [E. coli IFN4]</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="strain">
E. coli imp 4231(G93V)
      </Characteristics>
      <Characteristics tag="passage">
4
      </Characteristics>
      <Characteristics tag="imp mutation">
contains a 23 codon deletion allele in imp (increased membrane permeability),substitution of the 93th codon of fabI, NTG treatment; fabI(G93V), substitution of Gly(the 93th codon) of fabI with Val, NTG treatment to be high resistance to triclosan
      </Characteristics>
      <Characteristics tag="ntg treatment">
yes
      </Characteristics>
      <Characteristics tag="agent">
no triclosan
      </Characteristics>
      <Treatment-Protocol>
No triclosan treatment
      </Treatment-Protocol>
      <Growth-Protocol>
The cells were cultivated in 100 ml LB broth containing 2 mg/L Cm without triclosan and harvested in mid-logarithmic growth phase (OD600=1.0).
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA extracted using RNAprotect Bacterial Reagent (Qiagen) and an RNeasy Mini kit (Qiagen).
      </Extract-Protocol>
      <Label>Cy5</Label>
      <Label-Protocol>
The purified RNA (40 mg) was mixed with 2 mL of bacterial random primer (3 mg/mL), 10mL 5xFirst strand buffer (Invitrogen) 5 mL 0.1M DTT, 1 mL 50xaminoallyl-dNTP mixture (0.5 mM each of dATP, dGTP, dCTP and dTTP), 1mL RNasin (40 U/mL) (Promega) and 2 mL reverse transcriptase (200 U/mL) (Invitrogen), and was incubated at 42°C for 1 h. After a further incubation with 1 mL reverse transcriptase (200 U/mL) at 42 °C for 1 h, 16.5 mL 1M NaOH and 16.5 mL 0.5 M EDTA were added to the mixture and incubated at 65 °C for 15 min to degrade the RNA. HCl (16.5 mL, 1M) was added to neutralize the mixture. The synthesized cDNA mixtures were purified using Microcon YM-30 (Millipore) and eluted. The purified cDNA was mixed with 1 m L 1M Na2CO3 (pH 9.0) and 2 mL Cy3-OSu or Cy5-OSu (Amersham Pharmacia Biotech) and incubated at room temperature for 1 h in the dark. The two labeled cDNA samples to be compared were purified using a QIAquick PCR purification kit (Qiagen), and the eluted cDNA was dried by SpeedVac.
      </Label-Protocol>
    </Channel>
    <Channel position="2">
      <Source>E. coli imp fabI(G93V) [control]</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="strain">
E. coli imp 4231(G93V), substitution of the 93th codon of fabI
      </Characteristics>
      <Characteristics tag="imp mutation">
contains a 23 codon detion allele in imp (increased membrane permeability),substitution of the 93th codon of fabI; fabI(G93V), substitution of Gly(the 93th codon) of fabI with Val
      </Characteristics>
      <Treatment-Protocol>
No triclosan treatment
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA extracted using RNAprotect Bacterial Reagent (Qiagen) and an RNeasy Mini kit (Qiagen).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
The purified RNA (40 mg) was mixed with 2 mL of bacterial random primer (3 mg/mL), 10mL 5xFirst strand buffer (Invitrogen) 5 mL 0.1M DTT, 1 mL 50xaminoallyl-dNTP mixture (0.5 mM each of dATP, dGTP, dCTP and dTTP), 1mL RNasin (40 U/mL) (Promega) and 2 mL reverse transcriptase (200 U/mL) (Invitrogen), and was incubated at 42°C for 1 h. After a further incubation with 1 mL reverse transcriptase (200 U/mL) at 42 °C for 1 h, 16.5 mL 1M NaOH and 16.5 mL 0.5 M EDTA were added to the mixture and incubated at 65 °C for 15 min to degrade the RNA. HCl (16.5 mL, 1M) was added to neutralize the mixture. The synthesized cDNA mixtures were purified using Microcon YM-30 (Millipore) and eluted. The purified cDNA was mixed with 1 m L 1M Na2CO3 (pH 9.0) and 2 mL Cy3-OSu or Cy5-OSu (Amersham Pharmacia Biotech) and incubated at room temperature for 1 h in the dark. The two labeled cDNA samples to be compared were purified using a QIAquick PCR purification kit (Qiagen), and the eluted cDNA was dried by SpeedVac.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
The dried labeled probes were resuspended in 30 mL hybridization buffer (25% formamide, 5xSSC, 0.1% SDS, 10% dextran sulfate) and incubated at 95 °C for 5 min to denature the labeled probes. Each labeled probe was mixed and applied to the microarray slide and covered with a cover-slip. Hybridization was carried out in a humidified slide chamber (Corning) submerged in a 42 °C water bath for over 16 h. The cover-slips were removed by incubation for 1 min in wash buffer I (2xSSC and 0.1% SDS) prewarmed to 42 °C, and the slides were washed sequentially in washing buffer I at 42 °C for 10 min in the dark, washing buffer II (0.1xSSC and 0.1% SDS) at room temperature for 10 min in the dark, and twice in washing buffer III (0.1xSSC) at room temperature for 1 min. Finally, the slides were dried by centrifugation at 700 rpm for 5 min.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanned on a GenePix 4000B scanner (Axon Instruments). The resulting images were analyzed using GenePix Pro 6.0 software (Axon Instruments), and the data were imported into Genespring software for further analysis.
    </Scan-Protocol>
    <Description>
no additional information
    </Description>
    <Data-Processing>
LOWESS normalized, background subtracted data obtained from log2 of processed Red signal/processed Green signal. Agilent software GX 7.3 was used.
    </Data-Processing>
    <Platform-Ref ref="GPL5482" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM435nnn/GSM435073/GSM435073_No_Triclosan-raw_data-1-lower.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM435nnn/GSM435073/GSM435073_No_Triclosan-raw_data-1-upper.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM435nnn/GSM435073/GSM435073_No_Triclosan-raw_data-2-lower.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM435nnn/GSM435073/GSM435073_No_Triclosan-raw_data-2-upper.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM435nnn/GSM435073/GSM435073_No_Triclosan-raw_data-3-lower.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM435nnn/GSM435073/GSM435073_No_Triclosan-raw_data-3-upper.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM435nnn/GSM435073/GSM435073_No_Triclosan-raw_data-4-lower.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM435nnn/GSM435073/GSM435073_No_Triclosan-raw_data-4-upper.txt.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>normalized Log2 ratio (Cy5/Cy3) representing test/reference</Description>
      </Column>
    <External-Data rows="4819">
GSM435073-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM435074">
    <Status database="GEO">
      <Submission-Date>2009-07-30</Submission-Date>
      <Release-Date>2009-07-31</Release-Date>
      <Last-Update-Date>2009-07-31</Last-Update-Date>
    </Status>
    <Title>Transcription profiles of NTG-treated E. coli imp fabI(G93V) and its control strain in the presence of triclosan</Title>
    <Accession database="GEO">GSM435074</Accession>
    <Type>RNA</Type>
    <Channel-Count>2</Channel-Count>
    <Channel position="1">
      <Source>NTG-treated E. coli imp fabI(G93V) [E. coli IFN5]</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="strain">
E. coli imp 4231(G93V)
      </Characteristics>
      <Characteristics tag="passage">
4
      </Characteristics>
      <Characteristics tag="imp mutation">
contains a 23 codon deletion allele in imp (increased membrane permeability),substitution of the 94th codon of fabI, NTG treatment; fabI(G93V), substitution of Gly(the 94th codon) of fabI with Val, NTG treatment to be high resistance to triclosan
      </Characteristics>
      <Characteristics tag="ntg treatment">
yes
      </Characteristics>
      <Characteristics tag="agent">
triclosan
      </Characteristics>
      <Treatment-Protocol>
Treatment of sub-lethal triclosan; 50 mg/L triclosan
      </Treatment-Protocol>
      <Growth-Protocol>
The cells were cultivated in 100 ml LB broth containing 2 mg/L Cm with  50 mg/L triclosan and harvested in mid-logarithmic growth phase (OD600=1.1).
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA extracted using RNAprotect Bacterial Reagent (Qiagen) and an RNeasy Mini kit (Qiagen).
      </Extract-Protocol>
      <Label>Cy5</Label>
      <Label-Protocol>
The purified RNA (40 mg) was mixed with 2 mL of bacterial random primer (3 mg/mL), 10mL 5xFirst strand buffer (Invitrogen) 5 mL 0.1M DTT, 1 mL 50xaminoallyl-dNTP mixture (0.5 mM each of dATP, dGTP, dCTP and dTTP), 1mL RNasin (40 U/mL) (Promega) and 2 mL reverse transcriptase (200 U/mL) (Invitrogen), and was incubated at 42°C for 1 h. After a further incubation with 1 mL reverse transcriptase (200 U/mL) at 42 °C for 1 h, 16.5 mL 1M NaOH and 16.5 mL 0.5 M EDTA were added to the mixture and incubated at 65 °C for 15 min to degrade the RNA. HCl (16.5 mL, 1M) was added to neutralize the mixture. The synthesized cDNA mixtures were purified using Microcon YM-30 (Millipore) and eluted. The purified cDNA was mixed with 1 m L 1M Na2CO3 (pH 9.0) and 2 mL Cy3-OSu or Cy5-OSu (Amersham Pharmacia Biotech) and incubated at room temperature for 1 h in the dark. The two labeled cDNA samples to be compared were purified using a QIAquick PCR purification kit (Qiagen), and the eluted cDNA was dried by SpeedVac.
      </Label-Protocol>
    </Channel>
    <Channel position="2">
      <Source>E. coli imp fabI(G94V) [control]</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="strain">
E. coli imp 4231(G93V), substitution of the 94th codon of fabI
      </Characteristics>
      <Characteristics tag="imp mutation">
contains a 23 codon detion allele in imp (increased membrane permeability),substitution of the 94th codon of fabI; fabI(G93V), substitution of Gly(the 94th codon) of fabI with Val
      </Characteristics>
      <Treatment-Protocol>
No triclosan treatment
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA extracted using RNAprotect Bacterial Reagent (Qiagen) and an RNeasy Mini kit (Qiagen).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
The purified RNA (40 mg) was mixed with 2 mL of bacterial random primer (3 mg/mL), 10mL 5xFirst strand buffer (Invitrogen) 5 mL 0.1M DTT, 1 mL 50xaminoallyl-dNTP mixture (0.5 mM each of dATP, dGTP, dCTP and dTTP), 1mL RNasin (40 U/mL) (Promega) and 2 mL reverse transcriptase (200 U/mL) (Invitrogen), and was incubated at 42°C for 1 h. After a further incubation with 1 mL reverse transcriptase (200 U/mL) at 42 °C for 1 h, 16.5 mL 1M NaOH and 16.5 mL 0.5 M EDTA were added to the mixture and incubated at 65 °C for 15 min to degrade the RNA. HCl (16.5 mL, 1M) was added to neutralize the mixture. The synthesized cDNA mixtures were purified using Microcon YM-30 (Millipore) and eluted. The purified cDNA was mixed with 1 m L 1M Na2CO3 (pH 9.0) and 2 mL Cy3-OSu or Cy5-OSu (Amersham Pharmacia Biotech) and incubated at room temperature for 1 h in the dark. The two labeled cDNA samples to be compared were purified using a QIAquick PCR purification kit (Qiagen), and the eluted cDNA was dried by SpeedVac.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
The dried labeled probes were resuspended in 30 mL hybridization buffer (25% formamide, 5xSSC, 0.1% SDS, 10% dextran sulfate) and incubated at 95 °C for 5 min to denature the labeled probes. Each labeled probe was mixed and applied to the microarray slide and covered with a cover-slip. Hybridization was carried out in a humidified slide chamber (Corning) submerged in a 42 °C water bath for over 16 h. The cover-slips were removed by incubation for 1 min in wash buffer I (2xSSC and 0.1% SDS) prewarmed to 42 °C, and the slides were washed sequentially in washing buffer I at 42 °C for 10 min in the dark, washing buffer II (0.1xSSC and 0.1% SDS) at room temperature for 10 min in the dark, and twice in washing buffer III (0.1xSSC) at room temperature for 1 min. Finally, the slides were dried by centrifugation at 700 rpm for 5 min.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanned on a GenePix 4000B scanner (Axon Instruments). The resulting images were analyzed using GenePix Pro 6.0 software (Axon Instruments), and the data were imported into Genespring software for further analysis.
    </Scan-Protocol>
    <Description>
no additional information
    </Description>
    <Data-Processing>
LOWESS normalized, background subtracted data obtained from log2 of processed Red signal/processed Green signal. Agilent software GX 7.3 was used.
    </Data-Processing>
    <Platform-Ref ref="GPL5482" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM435nnn/GSM435074/GSM435074_Sublethal-triclosan-raw_data-1-lower.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM435nnn/GSM435074/GSM435074_Sublethal-triclosan-raw_data-1-upper.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM435nnn/GSM435074/GSM435074_Sublethal-triclosan-raw_data-2-lower.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM435nnn/GSM435074/GSM435074_Sublethal-triclosan-raw_data-2-upper.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM435nnn/GSM435074/GSM435074_Sublethal-triclosan-raw_data-3-lower.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM435nnn/GSM435074/GSM435074_Sublethal-triclosan-raw_data-3-upper.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM435nnn/GSM435074/GSM435074_Sublethal-triclosan-raw_data-4-lower.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM435nnn/GSM435074/GSM435074_Sublethal-triclosan-raw_data-4-upper.txt.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>normalized Log2 ratio (Cy5/Cy3) representing test/reference</Description>
      </Column>
    <External-Data rows="4819">
GSM435074-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Series iid="GSE17441">
    <Status database="GEO">
      <Submission-Date>2009-07-30</Submission-Date>
      <Release-Date>2009-07-31</Release-Date>
      <Last-Update-Date>2012-03-21</Last-Update-Date>
    </Status>
    <Title>E. coli imp fabI(G93V) Mutant Cells: Control (E. coli imp fabI(G93V) ) vs. NTG-treated E. coli imp fabI(G93V)</Title>
    <Accession database="GEO">GSE17441</Accession>
    <Pubmed-ID>20410062</Pubmed-ID>
    <Summary>
Transcriptional profiling of NTG-treated E. coli imp fabI(G93V) cells compared to control cells (E. coli imp fabI(G93V) ) in the absence or presence of sub-lethal concentration of triclosan.
    </Summary>
    <Overall-Design>
Two-condition experiments with NTG-treated E. coli imp fabI(G93V) vs. control E. coli imp fabI(G93V). Biological replicates: 1 control (E. coli imp fabI(G93V) cell), 1 sample (NTG-treated E. coli imp fabI(G93V) cell), independently grown and harvested. Two replicate per array.
    </Overall-Design>
    <Type>Expression profiling by array</Type>
    <Contributor-Ref ref="contrib10" position="1" />
    <Contributor-Ref ref="contrib11" position="2" />
    <Contact-Ref ref="contrib1" />
    <Sample-Ref ref="GSM435073" />
    <Sample-Ref ref="GSM435074" />
    <Supplementary-Data type="TAR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/series/GSE17441/GSE17441_RAW.tar
    </Supplementary-Data>
    <Relation type="BioProject" target="http://www.ncbi.nlm.nih.gov/bioproject/118863" />
  </Series>

</MINiML>
